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In response to vascular injury, vascular smooth muscle cells (VSMCs)
may switch from a contractile to a proliferative phenotype thereby
contributing to neointima formation. Previous studies showed that
the long noncoding RNA (lncRNA) NEAT1 is critical for paraspeckle
formation and tumorigenesis by promoting cell proliferation and
migration. However, the role of NEAT1 in VSMC phenotypic modu-
lation is unknown. Herein we showed that NEAT1 expression was
induced in VSMCs during phenotypic switching in vivo and in vitro.
Silencing NEAT1 in VSMCs resulted in enhanced expression of SM-
specific genes while attenuating VSMC proliferation and migration.
Conversely, overexpression of NEAT1 in VSMCs had opposite ef-
fects. These in vitro findings were further supported by in vivo
studies in which NEAT1 knockout mice exhibited significantly de-
creased neointima formation following vascular injury, due to at-
tenuated VSMC proliferation. Mechanistic studies demonstrated
that NEAT1 sequesters the key chromatin modifier WDR5 (WD Re-
peat Domain 5) from SM-specific gene loci, thereby initiating an
epigenetic “off” state, resulting in down-regulation of SM-specific
gene expression. Taken together, we demonstrated an unexpected
role of the lncRNA NEAT1 in regulating phenotypic switching by
repressing SM-contractile gene expression through an epigenetic
regulatory mechanism. Our data suggest that NEAT1 is a therapeutic
target for treating occlusive vascular diseases.
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Vascular smooth muscle cells (VSMCs) are a major componentof the vascular wall. In response to vascular injury, VSMCs
may switch from a contractile to a “synthetic” phenotype that is
characterized by increased motility and proliferation as well as re-
duced expression of contractile proteins such as calponin (CNN1),
SM22α (transgelin, TAGLN), SM MHC (myosin heavy chain,
MYH11), SM α-actin (ACTA2), and Hic-5 (TGFB1I1) (1). Many
occlusive vascular diseases in humans, including intimal hyper-
plasia after angioplasty, atherosclerosis, and restenosis following
vascular interventions, are largely dependent upon VSMC phe-
notype modulation, contributing to progression of intimal lesions
that compromise vessel patency (1, 2). Although many studies
have shown that, following arterial injury and in atherosclerosis
neointima, VSMCs mostly originate from the local vessel wall (3–
10), there remains a lack of knowledge of the factors that can
control the switch of SM phenotype in vascular diseases.
Previous studies have shown that serum response factor (SRF)
is a critical transcription factor for regulating expression of many
SM-specific contractile genes (11). SRF is a multifunctional
protein that not only binds a highly conserved cis-regulatory
element CC(A/T)6GG, termed a CArG box that can be found
in most SM-specific gene loci, but also interacts with a wide
variety of accessory cofactors (11). WDR5 (WD Repeat Do-
main 5), a long noncoding RNA (lncRNA) binding protein
(12) and a critical adaptor protein in histone 3 lysine 4 (H3K4)
methyltransferase complexes (13), has been shown to play a
crucial role in SM differentiation by promoting active chro-
matin, thereby allowing SRF to bind to CArG boxes of SM-
specific genes (14). However, how the function of WDR5 is
regulated to control SM-contractile protein gene expression is
largely unknown.
In sharp contrast to the <3% of human genomic DNA that is
transcribed and ultimately translated into protein, >80% of
genomic DNA is capable of being transcribed but does not
encode for protein (15, 16). Depending upon the length of the
transcript, noncoding RNA can be divided into small (<200 nt)
and long noncoding RNA (lncRNA, >200 nt) (17). Originally,
the large number of noncoding transcripts were regarded as
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“junk” products, but emerging evidence suggests that a significant
portion of lncRNAs are critical for control of gene expression
during development and under pathological conditions (17). De-
spite some recent progress (18–21), most of the lncRNAs that are
functionally important in regulating VSMC phenotypic switching
remain to be identified.
Fig. 1. NEAT1 is induced in balloon-injured rat carotid arteries. (A) The qRT-PCR was performed to assess NEAT1 expression in rat carotid artery post-balloon
injury at the time as indicated; n = 5 rats for each time point. *P < 0.05. Error bars indicate standard deviation. (B) Seven days after rat carotid artery balloon
injury, control right common carotid artery (RCA) (Left) or injured left common carotid (LCA) (Middle) were sectioned for RNA-FISH to visualize NEAT1 (green), as
indicated by arrows. Cell nuclei were stained with DAPI (blue). The section hybridized with NEAT1 sense (S) probe was used as a negative control (Right). Dashed
lines denote external or internal elastic lamina. AD, adventitia layer; M, media layer; NI, neointima layer. The representative images shown are chosen from
three rats. (C) RNA-FISH/IF were performed to stain NEAT1 (green, arrows) and SM α-actin (red) in human carotid endarterectomy specimen (Left). Sections with
NEAT1 S probe and second antibody (Right) served as negative control. The representative images shown are selected from three human specimens.
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Fig. 2. NEAT1 is induced in response to SM phenotypic switching in vitro. (A) The qRT-PCR was performed to evaluate NEAT1 expression using the aortic tissues
either from the freshly isolated rat thoracic aorta (0 h) or rat thoracic aorta cultured in 20% FBS for the times as indicated; n = 4. *P < 0.05. (B) The qRT-PCR was
performed to assessNEAT1 expression in fresh rat aortic tissue or second passage enzymatically dispersed rat aortic VSMCs; n = 4. *P < 0.05. (C) Rat primary aortic
VSMCs were treated with PDGF-BB (25 ng/mL) for 8 h or 24 h as indicated, and NEAT1 expression was measured by qRT-PCR; n = 3. *P < 0.05. (D) Rat aortic SMCs
were treated without (Left) or with (Middle) PDGF-BB (25 ng/mL) for 24 h, and then RNA-FISH assays were performed to visualize NEAT1 expression. Arrows
indicate the representative NEAT1 signal. Cells treated with PDGF-BB and hybridized with NEAT1 sense (S) probe served as the negative control (Right). (E) The
numbers of RNA-FISH NEAT1 foci per cell with or without PDGF-BB treatment in HCASMCs (in D) were manually counted and plotted; n = 3. *P < 0.05.
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Paraspeckles are nuclear bodies that are typically detected as
foci in close proximity to nuclear speckles and are enriched with
RNA-binding proteins such as splicing factor proline/glutamine-rich
(SFPQ), paraspeckle component 1 (PSPC1), and non-POU domain
containing octamer binding (NONO) that binds to the lncRNA
NEAT1 (nuclear paraspeckle assembly transcript 1) (22). In hu-
mans,NEAT1 has two splice variants, NEAT1_1 (V1) (∼3,700 nt)
and NEAT1_2 (V2) (∼23K nt) (22, 23). Although the homology of
NEAT1 exons among mammals is relatively low, the function of
NEAT1 in paraspeckle formation is conserved from mouse to hu-
man (22, 23). Both of the NEAT1 variants can be found in para-
speckles, where they bind resident proteins to maintain architec-
tural integrity of the paraspeckle (22, 24), although a recent study
showed that NEAT1 V1 can be also found in microspeckles (25).
Previous studies have demonstrated that paraspeckles are not only
subnuclear structures but also regulate the expression of a number
of genes via the sequestration of specific proteins and RNAs (26–
28). In particular, the paraspeckle lncRNA NEAT1 is critical for
IL-8 production in response to viral infection (28) and for pro-
moting tumorigenesis in breast and prostate cancers (29, 30).
However, little is known about the functional role of NEAT1 in
VSMCs during VSMC phenotypic modulation.
In this study, we discovered that the lncRNA NEAT1 is induced
in response to arterial injury and is a previously unrecognized co-
ordinator of VSMC phenotype, which can down-regulate contractile
gene expression and promote VSMC proliferation and migration
through regulating the lncRNA binding protein WDR5.
Methods
Rat balloon angioplasty was carried out as previously described (31, 32).
RNA-FISH (fluorescence in situ hybridization) was performed following the pro-
tocol as previously described (33).NEAT1 KO (knockout) mice were generated and
maintained in C57BL/6 strain background, and left carotid artery ligation injury
was carried out as previously described (32, 34). The use of experimental rats and
mice for arterial injury procedures, including BSL-2 viral work, was approved by
the Institutional Animal Care and Use Committee and Biosafety committees at
Augusta University. Full materials and methods are detailed in SI Appendix.
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Fig. 3. NEAT1 attenuates SM-specific gene expression. (A) Heat map of mRNAs differentially expressed between control and NEAT1 knockdown HCASMCs,
as revealed by RNA-seq with cutoff of FDR < 0.01 and FC (fold change) >2; n = 3 each group. (B) GO analysis of the differentially expressed genes between
silencing control and silencing NEAT1 in HCAMSCs. (C) Heat map of significantly up-regulated SRF-dependent contractile genes in silencing NEAT1 compared
with silencing control in HCASMCs. HCASMCs were transduced with scrambled control siRNA or two different NEAT1 siRNA duplexes and harvested for (D)
qRT-PCR or (E) Western blotting analysis as indicated. *P < 0.05. (F) RT-PCR was performed to validate the exogenous mouse NEAT1 expression using the
mouse or human NEAT1 specific primers after control GFP or mouse NEAT1 V1 adenovirus was transduced into HCASMCs for 48 h. (G) Western blot was
performed to examine protein expression in GFP or NEAT1 overexpressing HCASMCs.
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Results
NEAT1 Expression Is Increased in VSMCs Following Arterial Injury. A
mounting body of evidence suggests the lncRNA NEAT1 plays a
critical role in tumorigenesis by promoting cell proliferation and
migration, but little is known about whetherNEAT1 has any function
in VSMCs. As an initial step to examine the function of NEAT1 in
VSMCs, we performed qRT-PCR assay to assess NEAT1 expression
by using the RNA samples harvested from control or carotid arteries
injured by a balloon denudation, a model resembling human angio-
plasty procedures in which VSMCs convert from a contractile to
synthetic phenotype and contribute to neointima formation (35).
The qRT-PCR results revealed that NEAT1 was significantly ele-
vated twofold and fivefold 3 and 7 d postinjury, respectively, during
the onset of maximal VSMC proliferation and migration (35, 36)
(Fig. 1A). RNA-FISH assays further revealed that NEAT1 was
rarely detectable in the medial VSMCs of control intact arteries
(Fig. 1B, Left and SI Appendix, Fig. S1), but were readily detectable
in the nuclei of neointimal cells (Fig. 1B,Middle, arrows), which are
mostly dedifferentiated VSMCs (35). Similarly, we also found that
NEAT1 is readily detectable in human advanced carotid athero-
sclerotic plaque (Fig. 1C, Left), suggesting a conservation of the
potential NEAT1 function between rodent and humans. Together,
these data demonstrate that NEAT1 expression is induced in
neointimal VSMCs in response to arterial injury.
NEAT1 Expression Is Induced During SM Phenotypic Modulation in
Vitro. To extend the in vivo findings (Fig. 1) to in vitro, we next
sought to determine the expression level of NEAT1 during SM
phenotypic switching in in vitro settings. In culture, rat aortic tis-
sue undergoes a dramatic switch toward a synthetic proliferative
phenotype (37, 38) that is associated with significantly increased
expression of NEAT1 in a time-dependent manner (Fig. 2A). Dur-
ing dedifferentiation of VSMCs induced by primary culture (37),
NEAT1 expression was significantly induced (Fig. 2B). In response
to PDGF-BB, a growth factor known to further inhibit SM con-
tractile protein expression while promoting VSMC proliferation
and migration (39),NEAT1 expression was significantly up-regulated
in a time-dependent manner (Fig. 2C). RNA-FISH assays further
revealed the induced expression of NEAT1 in PDGF-BB−treated
rat aortic primary VSMCs (Fig. 2 D and E). Taken together, these
data demonstrate that NEAT1 expression is induced in pheno-
typically modulated synthetic VSMCs in vitro.
NEAT1 Suppresses SM-Specific Gene Expression. Since NEAT1 ex-
pression was elevated in tandem with the reduction of SM-specific
markers during SM phenotypic switching in vivo and in vitro, we
next sought to investigate the function of NEAT1 in SM-specific
gene expression by loss- or gain-of-function assays. First, we ex-
amined the effects of NEAT1 depletion on VSMC transcriptome
by performing RNA-sequencing (RNA-seq) analysis. RNA-seq
data revealed that silencing NEAT1 results in significant down-
regulation of both V1 and V2 isoforms but not its adjacent lncRNA
NEAT2 (also known as MALAT1; SI Appendix, Fig. S2). Using a
twofold cutoff and false discovery rate (FDR) of <0.01 threshold for
inclusion, RNA-seq data further revealed that silencing NEAT1
in HCASMCs (human coronary artery smooth muscle cells) sig-
nificantly down-regulated 371 genes while up-regulating 499 genes
(Fig. 3A and Dataset S1). Gene ontology (GO) enrichment analy-
sis revealed that these genes are associated with SM contraction
in addition to many signaling pathways related to tumorigenesis
such as Hippo signaling (32). Interestingly, among those genes up-
regulated after silencing NEAT1, there are a large set of SRF-
dependent genes encoding SM contractile proteins such as calpo-
nin (CNN1), SM22α (TAGLN), SM MHC (MYH11), SM α-actin
(ACTA2), Hic-5 (TGFB1I1), and myocardin (MYOCD), a potent
SRF cofactor critical for promoting VSMC myogenesis (40) (Fig.
3C). To further validate the findings, depletion of NEAT1 using an
additional siRNA duplex also significantly increased expression of
SM22α, calponin, Hic-5, and myocardin at both mRNA and protein
levels in HCASMCs, without affecting the expression of paraspeckle
NEAT1-binding proteins such as SFPQ, PSPC1, and NONO (Fig. 3
D and E). Moreover, silencing NEAT1 did not significantly alter
other key factors critical for regulation of SM-specific gene ex-
pression, including SRF, MKL1, and MKL2 (Fig. 3D). The in-
duction of endogenous SM-specific gene expression resulting from
silencing NEAT1 in VSMCs is unlikely an off-target effect, since
two different NEAT1 silencing duplexes have similar results. Fur-
thermore, overexpression of mouse NEAT1 V1 was sufficient to
reduce SM-specific gene expression in HCASMCs while having no
effect on paraspeckle protein expression (Fig. 3 F and G). As a
recent study showed that the paraspeckle protein SFPQ mediates
NEAT1 function to regulate IL-8 expression in response to viral
infection (28), we next sought to determine whether SFPQ plays a
role in regulating SM-specific gene expression by transfection of
silencing duplexes against SFPQ into HCASMCs. Data from this
experiment revealed that, in contrast to silencing NEAT1, depletion
of SFPQ did not have any effects on the endogenous SM contractile
Fig. 4. NEAT1 is required and sufficient to promote VSMC proliferation andmigration. (A) Control orNEAT1 silencing duplex #1was transfected into HCASMCs in full
medium or PDGF-BB−containing medium (25 ng/mL), and cell proliferation was measured using the cell proliferationWST-1 kit (Roche); n = 3. *P < 0.05. (B) HCASMCs
after transfectionwith control orNEAT1 #1 silencing duplex were counted at each time point as indicated; n = 3. *P < 0.05. Adenovirus encodingNEAT1 or control GFP
were transduced into HCASMCs, and then the proliferation was measured as described in A by (C) WST-1 assay or (D) cell counting; n = 3. *P < 0.05. (E) Quantification
of Boyden chamber assay to assess cell migration after 8-h plating of silencing duplex transfected or (F) viral transduced HCASMCs; n = 3. *P < 0.05.
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gene expression (SI Appendix, Fig. S3). Taken together, these data
demonstrate that NEAT1 plays a critical role in repressing SM-
specific gene expression independent of its paraspeckle binding
protein SFPQ.
NEAT1 Promotes VSMC Proliferation and Migration. KO of NEAT1
in female mice impairs alveolar cell proliferation, resulting in the
defects of mammary gland development (41). Recent studies also
demonstrated that NEAT1 promotes prostate and breast cancer cell
proliferation and survival (29, 30). Consistent with this, NEAT1 is
induced in arterial injury (Fig. 1) where neointimal VSMCs are
known to be proliferative. We therefore directly tested whether
NEAT1 is able to affect VSMC proliferation by silencing endog-
enous NEAT1 or overexpression of NEAT1 in HCASMCs. Data
from these experiments revealed that the rates of HCASMC
proliferation were inhibited by silencing endogenous NEAT1 ex-
pression and increased by NEAT1 overexpression, supporting a
positive role for the NEAT1 in regulating VSMC proliferation
(Fig. 4 A–D). Similarly, by using Boyden chamber assay, we found
that silencing endogenous NEAT1 in HCASMCs significantly im-
paired VSMC migration (Fig. 4E), while overexpression of NEAT1
significantly promoted VSMC migration in both full medium and
PDGF-BB−treated conditions (Fig. 4F). Taken together, these data
demonstrate that NEAT1 plays an integral role in SM phenotypic
modulation by suppressing SM contractile gene expression while
promoting VSMC proliferation and migration.
KO of NEAT1 Significantly Impairs VSMC Proliferation and Migration
and Attenuates Neointima Formation After Carotid Artery Ligation
Injury in Mice. In vitro gain- and loss-of-function assays suggest a
unique role of the paraspeckle lncRNA NEAT1 in suppressing
SM-specific gene expression while promoting VSMC migration
and proliferation (Figs. 3 and 4). Therefore, we next examined the
functional role of NEAT1 in neointima formation in vivo under
pathological conditions using NEAT1 KO mice (34). NEAT1 KO
mice do not exhibit apparent gross abnormalities at baseline except
for dysfunction of the corpus luteum (42) and in mammary gland
development in the female KO mice (41). We confirmed that
NEAT1 expression is completely depleted in the KO aorta (Fig.
5A). We further demonstrated that the VSMCs cultured from
NEAT1 KO mice show decreased cell proliferation capability (Fig.
5 B and C) and migration (Fig. 5D) compared with WT VSMCs.
Moreover, the neointima formed in response to carotid artery li-
gation for 28 d was significantly reduced in KO mice compared
with the WT counterparts (Fig. 5 E–H). Immunofluorescence (IF)
staining of proliferation marker Ki67 and SM-contractile gene SM
α-actin further revealed that the NEAT1 deficiency attenuated
VSMC proliferation after ligation injury (Fig. 5I). Taken together,
these data demonstrate that the lncRNA NEAT1 plays a critical
role for SM phenotypic switching in vitro and in vivo.
NEAT1 Induces an Inactive Chromatin State Within SM-Specific Gene
Promoters by Binding to the Epigenetic Activator WDR5.Data described
above demonstrated a function of NEAT1 in SM-contractile gene
expression in VSMCs; therefore, we next sought to determine the
mechanism by whichNEAT1 represses SM-specific gene expression.
We first knocked down NEAT1 in HCASMCs, and ChIP assays
were performed to examine the chromatin status by using a variety
of antibodies against modified histones, including transcriptionally
active marks H3K4me3, H3K9ac and the repressive mark
H3K27me3. Since SRF binding to the CArG boxes within SM-
specific gene promoters is the prerequisite to induce expression of
these genes, we also evaluated SRF binding to CArG box regions
within SM-specific gene promoters by using anti-SRF antibody.
Data from these ChIP assays revealed that depletion of NEAT1
significantly promoted the enrichment of active histone modifi-
cations (H3K4me3 and H3K9ac) while decreasing the enrichment
of inactive modification (H3K4me3) within CArG regions of SM-
specific genes, calponin, and SM22α, resulting in increased
binding of SRF to the CArG box regions of these genes (Fig. 6 A
and B). To further dissect the mechanism by which NEAT1 could
affect these histone modifications, we next sought to determine
which factors bind to NEAT1 in VSMCs. Biotin RNA pull-down
assays using nuclear protein extracted from PDGF-BB−treated or
nontreated HCASMCs revealed that NEAT1 lncRNA bound
WDR5 (12, 13, 43), a critical adaptor protein within MLL (Mixed
Lineage Leukemia) H3K4 methylase complexes that previously has
been shown to activate SM-specific gene expression (14, 44), and
that this binding increased in PDGF-BB−treated cells (Fig. 6C).
In contrast, SRF was absent from the NEAT1 RNA/protein com-
plex (Fig. 6C) and was not colocalized with NEAT1, as shown by
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Fig. 5. KO of NEAT1 impairs VSMC proliferation and migration and attenu-
ates neointima formation induced by ligation injury in mice. (A) The qRT-PCR
was performed to measure NEAT1 expression in thoracic aorta from WT or
NEAT1 KO mice; n = 4. *P < 0.05. Primary aortic VSMCs prepared from WT or
NEAT1 KO mice were subjected to (B) WST-1 assay and (C) cell number
counting to measure SMC proliferation or (D) Boyden chamber transwell assay
to measure SMC migration, as indicated; n = 3. *P < 0.05. (E) Adult WT or
NEAT1 KO mice were subjected to carotid artery ligation injury (LCA) for 28 d.
Representative hematoxylin- and eosin-stained sections show less neointima
formation in the KO mice compared with WT. Neointima lesions are outlined
with yellow lines. L, lumen; M, media layer; NI, neointima layer. (F) Costaining
of proliferative marker Ki67 (red) and SM-specific marker SM α-actin (green)
was performed in the ligation-injured LCA (28 d postinjury) fromWT or NEAT1
KO mouse. Nuclei were counterstained with DAPI (blue). Arrows point to the
representative Ki67 positive cells in neointima. Neointima lesions were out-
lined with yellow lines. Statistical analysis of (G) neointima area and (H)
neointima/media layer ratio of sections shown in F using ImageJ software; n =
7. *P < 0.05. (I) Quantification of the Ki67 positive SMCs within the neointima
area of the WT or NEAT1 KO LCA as shown in F; n = 7. *P < 0.05.
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RNA-FISH/IF assay (SI Appendix, Fig. S4). Data from RNA im-
munoprecipitation (RIP) assays further demonstrated that
NEAT1 was associated with WDR5 at basal level, but also the
binding was significantly enhanced by treatment with PDGF-BB
(Fig. 6D). Consistently, RNA-FISH/IF revealed that PDGF-BB
treatment not only induced NEAT1 expression but promoted
colocalization ofNEAT1 andWDR5 (Fig. 6 E and F). Since PDGF-
BB can promote NEAT1 binding with WDR5, we next directly
assessed WDR5 function in VSMCs by knocking down endogenous
WDR5 in HCASMCs. Protein lysate was harvested for Western
blot 48 h after transfection of silencing RNA duplex against WDR5.
Data from these experiments demonstrated that knockdown of
WDR5 significantly decreased endogenous SM-specific protein ex-
pression (Fig. 6G). This effect is most likely due to the condensed
chromatin configuration induced by depletion of WDR5 as shown
by the decreased enrichment of active histone modifications
(H3K4me3 and H3K9ac) and SRF binding along with enhanced
inactive modification (H3K4me3) within CArG regions of SM-
specific genes, calponin, and SM22α (Fig. 6 H and I). Taken to-
gether, these data suggest that NEAT1 functions through binding
with WDR5 to repress SM-specific gene expression in VSMCs.
In summary, our data suggest that, in contractile VSMCs, NEAT1
is expressed at a low level. Under these conditions, the WDR5
component of the MLL histone methytransferase complex is free to
facilitate an “open” configuration chromatin at the promoters of
SM-specific genes, thereby promoting SRF binding and transcrip-
tional activation (Fig. 7A). In contrast, in response to the stimuli that
promote VSMC dedifferentiation and proliferation such as PDGF-
BB, induced expression of lncRNA NEAT1 sequestrates WDR5
from SM-specific gene loci, thereby initiating an epigenetic “off”
state and consequently impairing SRF accessibility to the CArG
boxes, resulting in down-regulation of SM-specific gene expression
(Fig. 7B).
Discussion
This study provides evidence demonstrating a critical role for the
paraspeckle-specific lncRNA NEAT1 in promoting VSMC pro-
liferation, migration, and dedifferentiation during phenotypic
switching. Paraspeckles are mammal-specific nuclear bodies that
can be found in most cells cultured in vitro (45). NEAT1 is essen-
tial for the architectural integrity of paraspeckle by binding to
paraspeckle proteins such as SFPQ (22, 24). Our current study
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regulatory regions; n = 3. *P < 0.05. (C) Biotin labeled sense (S) or antisense (AS) humanNEAT1was incubatedwith the nuclear protein from HCASMCs treated with
or without PDGF-BB (25 ng/mL, 24 h), and Western blotting was performed to examine the proteins binding to NEAT1 by the indicated antibodies. (D) RIP assays
were performed to determine the association between NEAT1 and WDR5 with or without PDGF-BB treatment (25 ng/mL, 24 h). Primers designed for NEAT1 V1 or
V2 were utilized to measure the relative NEAT1 binding toWDR5. Samples immunoprecipitated with IgG served as control (set to 1). (E) RNA-FISH/IF was performed
to determine the colocalization of NEAT1 (green) andWDR5 (red) with or without PDGF-BB treatment (25 ng/mL, 24 h). Arrows point to the colocalized NEAT1 and
WDR5. (F) Quantification of the colocalized NEAT1 and WDR5 foci each cell as shown in D; n = 40 cells in each group. *P < 0.05. (G) Western blot was performed to
assess SM-specific gene expression after knockdown of WDR5 in HCASMCs for 48 h. (H) ChIP assays were performed as described in A and B, except HCASMCs were
transfected with silencing duplexes against WDR5 to determine epigenetic marks or SRF binding within calponin or SM22α gene (I); n = 3. *P < 0.05.
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revealed an unexpected role of NEAT1 in SM phenotypic switching
independent of its paraspeckle binding protein SFPQ (SI Appendix,
Fig. S3). We found that expression of NEAT1 is induced during
phenotypic modulation in VSMCs in vitro and in vivo (Figs. 1 and
2). Loss- and gain-of-function NEAT1 assays revealed that NEAT1
not only promotes proliferation and migration of VSMCs but also
decreases the expression of SM-specific contractile proteins (Figs. 3–
5). In contrast to the recent study which showed that the paraspeckle
protein SFPQmediates NEAT1 ability to regulate IL-8 expression in
response to viral infection (28), our data show that deletion of
NEAT1 binding protein SFPQ has no effects on SM-contractile
protein gene expression (SI Appendix, Fig. S3). It is unclear
whether the effects of NEAT1 on SM-specific gene expression
are dependent upon its function for the paraspeckle formation.
Interestingly, a previous study showed that NEAT2, a neighboring
lncRNA to NEAT1, is highly expressed in endothelial cells and is
critical for angiogenesis (46). Furthermore, knockdown of NEAT2 in
VSMCs has been shown to attenuate VSMC proliferation and mi-
gration (47), similar to our findings for NEAT1. Together with the
recent report demonstrating that knockdown of NEAT1 in endo-
thelial cells impaired the integrity and increased the permeability of
the blood−tumor barrier (48), it appears that lncRNA expression
from the clustered NEAT1 and NEAT2 loci is important for both
endothelial cells and VSMC phenotype.
Our mechanistic studies demonstrated that, in response to
PDGF-BB, a potent mitogen promoting SM phenotypic modula-
tion (39), NEAT1 bound the key chromatin modifier WDR5 and
led to decreased histone H3K4me3 and H3K9ac at the promoters
of SM-specific genes, thereby initiating an epigenetic off state and
resulting in down-regulation of SM-specific gene expression (Figs.
6 and 7). Our data also suggested that silencing ofNEAT1-mediated
SM gene expression occurs through promoting SRF binding to
CArG boxes, not through its expression level (Figs. 3D and 6 A
and B). A recent study showed that the SWI/SNF chromatin-
remodeling complexes were identified as paraspeckle components
that interact with NEAT1 (49). Our previous studies demon-
strated that Brahma (Brm) or Brahma-like gene 1 (Brg1), the
ATPase subunits of the SWI/SNF ATP-dependent chromatin
remodeling complex, is required for the expression of SM-specific
genes by promoting SRF/myocardin complex binding to the pro-
moters of these genes through facilitating an open chromatin state
within these gene loci (50). Interestingly, Capture Hybridization
Analysis of RNA Targets - Mass Spectrometry data from the
previous report suggested an association between NEAT1, BRG1,
and WDR5 in prostate cancer cells (29). Therefore, it is possible
that sequestration of Brg1 by NEAT1 in paraspeckles is an alter-
native mechanism accounting for the regulation of SM-specific
gene mediated by NEAT1 in VSMCs. Furthermore, our RNA-
seq data demonstrated that silencing NEAT1 in HCASMCs sig-
nificantly augmented expression of myocardin mRNA (Fig. 3 C
and D). Myocardin is a powerful SRF cofactor that is sufficient to
promote SM-specific gene expression in multiple cells (40, 51).
Interestingly, overexpression of myocardin facilitated an open
status of chromatin in SM-specific gene loci to allow SRF binding
and an active transcription of these genes (40), similar to the re-
sults after silencing NEAT1 in VSMCs (Fig. 6 A and B). Although
we did not have the direct evidence to show that myocardin bind
to NEAT1 in vitro, it is possible that NEAT1 can recruit myocardin
through other bridging factors in vivo, thereby displacing myocardin
from the SM gene. Therefore, it is likely that the augmentation of
SM-specific gene expression induced by silencing NEAT1 results
from a combination of myocardin induction and/or liberation of
WDR5, Brg1, and myocardin from NEAT1 complexes in VSMCs.
It has been documented that, in many solid tumors, including
those found in prostate cancer, lung cancer, esophageal cancer,
colorectal cancer, and hepatocellular carcinoma, the paraspeckle
lncRNA NEAT1 is overexpressed and NEAT1 promotes tumor
cell proliferation (52). In the current study, we found that
NEAT1 was also induced following vascular injury. Consistent with
the function of NEAT1 in promoting cancer cell proliferation, we
found overexpression of NEAT1 enhanced VSMC proliferation,
while knockdown or KO of NEAT1 attenuated VSMC proliferation
and migration, thereby diminishing neointima formation after vas-
cular injury (Figs. 4 and 5). GO analysis of mRNAs whose expres-
sions were altered following knockdown of NEAT1 revealed that
NEAT1 affects expression of many genes related to cell cycle and the
Hippo-YAP pathway in VSMCs (Fig. 3B) (32), suggesting that
NEAT1-mediated regulation of VSMC proliferation likely occurs
through multiple mechanisms, including modulating of Hippo path-
way activity and expression of cell cycle genes. Interestingly, we found
that NEAT1 expression was induced in adventitial cells after vascular
injury (Fig. 1B and SI Appendix, Fig. S1). Since there is emerging
evidence suggesting adventitial cells may be attributed to neointima
formation in addition to media layer VSMCs (53), future studies are
needed to investigate the potential role ofNEAT1 in adventitial cells.
Activation of hypoxia-inducible factor (HIF) is common in
many types of solid tumors. A recent study demonstrated that
NEAT1 was a direct transcriptional target of HIF in many breast
cancer cell lines and in solid tumors, thereby conferring HIF-
dependent gene regulation and eventually leading to accelerated
cellular proliferation (30). In addition, NEAT1 was identified as
a direct transcriptional target of ERα (estrogen receptor alpha)
and as an important mediator for maintenance of prostate cancer
progression (29). Furthermore, the transcription factor C/EBPβ
was critical for NEAT1 expression during acute promyelocytic
leukemia cell differentiation induced by all-trans retinoic acid
(54). In this study, we found that NEAT1 was significantly induced
A
B
Contractile VSMCs
Proliferative VSMCs
Fig. 7. Schematic summary of this study. (A) In contractile VSMCs, NEAT1 is
expressed at a low level, freeing the histone modifier WDR5 to trimethylate
histone H3K4 at the promoters of genes encoding SM contractile proteins,
thereby opening the chromatin at these loci, facilitating SRF binding and
transcriptional activation. WDR5 may possibly function through other
cofactors to modulate SM contractile gene expression, as indicated by a
question mark. (B) In contrast, in response to vascular injury or mitogens
such as PDGF-BB, the increased expression of lncRNA NEAT1 sequestrates
WDR5 from MLL complexes at the promoters of genes encoding SM-specific
contractile proteins, initiating an epigenetic off state and consequently
impairing SRF accessibility to the CArG boxes, resulting in down-regulation
of SM-specific gene expression.
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during SM phenotypic modulation in vivo and in vitro (Figs. 1 and
2). It will be important to investigate the underlying mechanisms
by which NEAT1 is induced in response to vascular injury and in
response to mitogens such as PDGF-BB.
In summary, this study has revealed an unexpected role of
NEAT1 in promoting VSMC phenotypic modulation that is me-
diated, at least in part, through NEAT1’s regulation of MLL
histone methyltransferase complexes. These findings suggest that
NEAT1 is a potential therapeutic target for treating occlusive
vascular diseases.
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